Clinical Trial Update: Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether calcium and magnesium can prevent ixabepilone-induced peripheral neuropathy in breast cancer patients was terminated, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Calcium (Calcium)
• Ixempra (ixabepilone)
• Magnesium (magnesium)

Snippet

Sponsor: Mayo Clinic | Conditions: Neuropathy, Pain | Phase 3 | Status: TERMINATED | Results posted: 2013-08-29